Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial Reply

被引：0
|
作者：
Beaulieu, Wesley T.
Bressler, Neil M.
Gross, Jeffrey G.
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 177卷
关键词：
D O I：
10.1016/j.ajo.2017.02.010
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [41] A RANDOMIZED CONTROLLED TRIAL OF PANRETINAL PHOTOCOAGULATION WITH AND WITHOUT INTRAVITREAL RANIBIZUMAB IN TREATMENT-NAIVE EYES WITH NON-HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY
    Ferraz, Daniel A.
    Vasquez, Lisa M.
    Preti, Rony C.
    Motta, Augusto
    Sophie, Raafay
    Bittencourt, Millena G.
    Sepah, Yasir J.
    Monteiro, Mario L. R.
    Quan Dong Nguyen
    Takahashi, Walter Yukihiko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (02): : 280 - 287
  • [42] SEVERE PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH VITRECTOMY OR PANRETINAL PHOTOCOAGULATION: A SINGLE CENTRE CONTROLLED CLINICAL TRIAL
    Avitabile, T.
    Bonfiglio, V.
    Castiglione, F.
    Castaing, M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 460 - 460
  • [43] Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation
    Messias, Katharina
    Barroso, Rafael de Montier
    Jorge, Rodrigo
    Messias, Andre
    DOCUMENTA OPHTHALMOLOGICA, 2018, 137 (02) : 121 - 129
  • [44] Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation
    Katharina Messias
    Rafael de Montier Barroso
    Rodrigo Jorge
    Andre Messias
    Documenta Ophthalmologica, 2018, 137 : 121 - 129
  • [45] Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Pattern Scan Laser Versus Argon Laser
    Chappelow, Aimee V.
    Tan, Kevin
    Waheed, Nadia K.
    Kaiser, Peter K.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (01) : 137 - 142
  • [46] Panretinal Photocoagulation Versus Intravitreal Injections in Proliferative Diabetic Retinopathy - The Best Way of Treatment
    Partyka, I.
    Czupryniak, L.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 : 25 - 26
  • [47] Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
    Nicholson, Luke
    Crosby-Nwaobi, Roxanne
    Vasconcelos, Joana C.
    Prevost, A. Toby
    Ramu, Jayashree
    Riddell, Amy
    Bainbridge, James W.
    Hykin, Philip G.
    Sivaprasad, Sobha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) : 4277 - 4284
  • [48] PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment
    Barroso, Rafael de Montier
    Messias, Andre
    Cardillo, Jose A.
    Jorge, Rodrigo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [49] Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial
    Nikkhah, Homayoun
    Ghazi, Hossein
    Razzaghi, Mohammad Reza
    Karimi, Saeed
    Ramezani, Alireza
    Soheilian, Masoud
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (01) : 313 - 321
  • [50] Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial
    Homayoun Nikkhah
    Hossein Ghazi
    Mohammad Reza Razzaghi
    Saeed Karimi
    Alireza Ramezani
    Masoud Soheilian
    International Ophthalmology, 2018, 38 : 313 - 321
12345